New laboratory research examining designed metronidazole derivatives and silver nanoparticle formulations as potential anti‑amoebic treatment candidates, promising for further preclinical study.
Key Takeaways
- Five metronidazole derivatives were designed and synthesized using in silico docking against EhTrxR
- Silver nanoparticles were green‑synthesized and measured between 29.54 and 53.48 nm in size
- Combined derivative plus AgNP formulations achieved up to 90% trophozoite mortality at 48 hours